European Business Summits
info@ebsummit.eu – 0032 (0) 2 645 34 80
TRANSPARENCY REGISTER 268958411031-65
PRIVACY-POLICY | GENERAL TERMS OF SALES
European Health Summit
2020 EDITION
Programme
08:50 – 08:55
WELCOME
Arnaud Thysen
Director General
European Business Summits
08:55 – 9:00
SPECIAL ADDRESS BY URSULA VON DER LEYEN, PRESIDENT OF THE EUROPEAN COMMISSION
Ursula von der Leyen
President of the European Commission
European Commission
SESSION HIGHLIGHTS
Ursula von der Leyen: “We have joined and contributed to the #COVAX facility to ensure that newly developed vaccines are also available for low and middle-income countries. / #HealthSummitEU “We will only defeat the virus if we defeat it all around the world.”
Ursula von der Leyen: President Vonderleyen detailed the creation of a new EU agency: the European Health Emergency Response Authority (HERA), an important new element to support a better EU level response to cross-border health threats. 1/2 / “HERA will focus on next crisis and avert them. From conception to deployment of therapies, vaccines and technologies, this kind of cooperation is essential to our rapid response in the event of a health emergency.” 2/2
09:00 – 09:45
OPENING: COVID-19 - BUILDING A MORE RESILIENT EUROPE
Frank Vandenbroucke
Deputy Prime Minister and
Minister for Social Affairs and Public Health
The Kingdom of Belgium
Hans Kluge
Regional Director for Europe
WHO
István Ujhelyi
Member of the European Parliament
European Parliament
Maria Tadeo
Reporter for Bloomberg Television
In the wake of the COVID-19 outbreak, it has become clear that European healthcare has been placed under immense strain pressure on European healthcare systems. Resiliency to a health crisis is now at the forefront of European healthcare as it develops after the pandemic. During the pandemic, it became clear that those who responded efficiently and in a timely manner were better off than others. However, the broad use of health data and mass screening, as well as the capacity to control personal protective equipment stocks were also determining factors. These are all areas in which EU action could mark a tangible added-value to member states’ capacity to handle a health crisis. The ability of European countries to address a health crisis hinges on the success of the collective response. However, the response to COVID-19 has been fragmented across the EU, with individual member states choosing their own strategy and reaction. This panel will draw upon lessons from the COVID-19 pandemic and discuss how a long-term vision for prevention and accessible treatment as well as the capacity to act promptly in health-related emergencies can build a more resilient Europe.
SESSION HIGHLIGHTS
Frank Vandenbroucke: “To maximise our chances, all EU countries should apply the same strategies and coordinate its policies.”/ “Success will depend on the level of cooperation of Member States, their transparency & an effective coordination between the authorities. Together, we will achieve better results than governments individually.”/”We ask the population for patience and solidarity. It is the only way to overcome the COVID19 crisis.” – Frank Vandenbroucke, Belgian Deputy Prime Minister and Minister for Social Affairs and Public Health
Hans Kluge: “Solidarity is a core ingredient for European resilience. No one is safe until everyone is safe.” @hans_kluge WHO Regional Director Europe.#UnitedActionForBetterHealth
SESSION HIGHLIGHTS
Frank Vandenbroucke: “To maximise our chances, all EU countries should apply the same strategies and coordinate its policies.”/ “Success will depend on the level of cooperation of Member States, their transparency & an effective coordination between the authorities. Together, we will achieve better results than governments individually.”/”We ask the population for patience and solidarity. It is the only way to overcome the COVID19 crisis.” – Frank Vandenbroucke, Belgian Deputy Prime Minister and Minister for Social Affairs and Public Health
Hans Kluge: “Solidarity is a core ingredient for European resilience. No one is safe until everyone is safe.” @hans_kluge WHO Regional Director Europe.#UnitedActionForBetterHealth
Istvan Ujhelyi: “The imbalance of healthcare in the EU must be addressed. We need a European Health Union and a strong one!.”/”COVID-19 highlighted that the European Union does not have the capacity to fight these kinds of infectious diseases… stress testing of healthcare systems need to be done in all member states to ensure that quality standards are met.”- MEP @istvan_ujhelyi
09:55 – 10:45
INTERACTIVE PANEL: DIGITAL TRANSFORMATION AND THE FUTURE OF HEALTHCARE
Bernd Montag
CEO
Siemens Healthineers
Kalle Killar
Deputy Secretary General
on E-services Development and Innovation
The Republic of Estonia
Khalil Rouhana
Deputy DG for Communications Networks,
Content and Technology
European Commission
Thomas Kostera
Senior Expert
Bertelsmann Stiftung
Johannes Schildt
CEO and Co-founder
KRY
Sébastien Deletaille
CEO and Co-founder
Rosa
The digital transformation of healthcare will be a key enabler to successfully maintain accessible and quality health systems across Europe. The future of such systems hinges on the outstanding efforts to provide affordable access to finite healthcare resources while ensuring medical quality for all. Digitisation can support these efforts and the transition to new care models, centered on predictive, preventive, and personalised medical care. The obstacles to the digital transformation are often non-technological and relate primarily to the mindset of practitioners and patients, organisational structures, and governance. The use of large data has undoubtedly an ethical dimension and we must ensure that it is not misused. Governments, businesses, and wellness providers in Europe therefore need to work together to unlock the much-needed digital transformation of the continent’s healthcare. The Summit will debate the forms of cooperation required to speed up digital healthcare transformation.
SESSION HIGHLIGHTS
Khalil Rouhana: “There is a major opportunity for #Europe when it comes to #healthcare and #digitalhealthcare to work together and to learn from each other, with the end of helping us to develop a common health policy.”/ “We are working on a large investment to be spread across member states to build up national health to have an EU wide data space… this is a great opportunity to upgrade our #healthdata spaces.”
Kalle Killar:“Thanks to the increase in demand from #COVID-19, #Estonia is currently working on #future tools for #healthcare data such as a genome bank and tools for doctors and citizens to use this for #personalisedmedicine.”/ “#Trust and #data privacy are key when thinking of #digitalisation. We need to consider the needs and wants of citizens and health professionals.” #HealthSummitEU
Thomas Kostera: @tomkostera-detailed the @BertelsmannSt project focused on patient-centered digital healthcare. Some key questions they are considering: What are the conditions for digital health – how do you scale up? What are the ethical issues? How do you train people? /”#Europe is already doing great things but going forward we need to reduce policy fragmentation and develop a clearer vision on where the EU should go with clear health policy goals and rules.”
Johannes Schildt: “#Europe has a chance to be at the forefront in this master transition in digital healthcare. This is a great opportunity to equalize access to healthcare among member-states and a shift to a more #proactive #healthcare system.”/”We need to have digital healthcare champions in this space. Policy, tech, and the industry need to work together to make sure that this happens.”-@jschildt @KRYcare
Bernd Montag: “When it comes to the professional use of #digitalhealth we are in a good space. We are strong in this area already.”/”When it comes to the 2 key issues topics for mankind and for Europe: #climatechange and #healthcare. #Europe can lead everyone in a safe and accessible way.” – @bernd_Montag CEO of @SiemensHealth
10:45 – 11:00
A CONVERSATION WITH OLIVIER VÉRAN, FRENCH MINISTER OF SOLIDARITY AND HEALTH
Olivier Véran
Minister of Solidarity and Health
The French Republic
Chris Burns
Independent Journalist
SESSION HIGHLIGHTS
Olivier Véran: “I am proud of the EU’s ability to place orders with several laboratories by ensuring a fair distribution of #vaccines throughout #Europe and being supportive of poorer countries.”/”We have created a free hotline with experts that receive over 20.000 calls/day & have created an indicator of early deterioration of the population’s mental health. We have to support each other and face this #pandemic together.”/ “Digitalisation is essential. France has invested an additional 2.5 billion EUR to help the digitalisation of the #healthcare infrastructures.” @olivierveran – French Minister of Solidarity and Health #COVID19
11:00 – 12:00
INTERACTIVE PANEL: SUSTAINABLE HEALTHCARE AND INNOVATIVE MEDICINE
Reda Guiha
Regional President
International Development Markets Rare Disease
Pfizer
Jean-Charles Samuelian-Werve
CEO and Co-founder
Alan
Giulia Del Brenna
DG GROW Health files coordinator
European Commission
Sam Proesmans
Public Health Advisor focusing on COVID-19
Cabinet of the Prime Minister of Belgium
Maria Tadeo
Reporter for Bloomberg Television
Sustainable healthcare depends on the financial viability of health systems. For decades healthcare costs in Europe have consistently outgrown economic growth. It begs the question of whether the challenges of sustainability and expansion can be dealt with by traditional responses and practices. Innovative medicine is an undeniable driver for high-quality healthcare. It has the potential to reshape these systems, but existing models of governance including payment systems tend to slow their adoption. The simultaneous evolution of personalized medicine challenges traditional healthcare models. The Summit will discuss the financial sustainability of healthcare systems against the backdrop of the changing healthcare landscape driven by innovative, personalised medicine.
SESSION HIGHLIGHTS
Reda Guiha: How key is #innovation in #healthcare? “Innovative medicines are an enabler for #EU healthcare sustainability. Two key areas: 1.#Collaboration between private and public actors; and 2. Outcomes and health benefits for patients”/”Collaboration and partnerships among actors in the healthcare sector are crucial. They have enabled an acceleration of the development of vaccines.”/”Pfizer’s purpose is to work on groundbreaking innovations that will change lives. It is our duty to provide patients with the innovation they deserve.” – Reda Guiha @pfizer @PfizerEUPolicy
Jean-Charles Samuelian-Werve: “The current crisis has created an opportunity on collaborative discussions. We need to keep that trend in the next year.” @jcsamuelian @avec_alan
Sam Proesmans: “#real world data is key to reflecting real life when it comes to clinical trials in data.”/ “The EU has largely underfunded prevention. That is how the pandemic got out of hand.” – @sam_proesmans, advisor for the prime minister of Belgium.
Giulia Del Brenna: “The #COVID19 crisis showed very clearly what we do well, what we can improve, what should be more centralised & what belongs to the competence of the #EU Member States.”/ In response to why the EU’s process is slower than the US… “We have to maintain our standards of efficacy when it comes to new #pharmaceuticals without compromising on safety. Trust is #key – we need to keep the trust of citizens.”
12:05 – 12:20
A CONVERSATION WITH JEAN STÉPHENNE, CHAIRMAN OF SUPERVISORY BOARD OF CUREVAC
Jean Stéphenne
Chairman of the Supervisory Board
CureVac
Maria Tadeo
Reporter for Bloomberg Television
SESSION HIGHLIGHTS
Jean Stéphenne: How quickly will the first #COVID19 #Vaccines enter the EU market? “The European registration process is very well organized. I am confident that the vaccines will be available in the following weeks”./ What about a mandatory #vaccine? “First convince with incentives, then gently force. There will always be anti-vaccine people, but reason should prevail!” – Jean Stéphenne, CureVac Chairman of the Supervisory Board
12:20 – 12:30
CONVERSATION WITH FRANK VANDENBROUCKE, BELGIAN MINISTER FOR SOCIAL AFFAIRS AND PUBLIC HEALTH
Frank Vandenbroucke
Deputy Prime Minister and
Minister for Social Affairs and Public Health
The Kingdom of Belgium
Maria Tadeo
Reporter for Bloomberg Television
SESSION HIGHLIGHTS
Frank Vandenbroucke: #HealthSummitEU #PrivateSector: “We organise economic support but we know it doesn’t diminish the hardship. Economy recovery & public health are interdependent. The worst case scenario is: we loosen up too quickly and then we encounter a third wave.”
12:30 – 13:15
A CONVERSATION ON MENTAL HEALTH
H. M. the Queen
of the Belgians
Paul Stoffels, M.D.
Vice Chairman of the Executive Committee
and Chief Scientific Officer
Johnson & Johnson
Hans Kluge
Regional Director for Europe
WHO
Arnaud Thysen
Director General
European Business Summits
Mental health is often overlooked. Yet, it can ruin lives and damage families, communities, and societies. One in four people worldwide are affected by a mental or neurological disorder at some point in their lives. Every forty seconds someone around the world commits suicide. The policy and financial resources dedicated to mental health do not match the need nor the investment in other disease areas. Mental health is a key component of individual wellbeing, as well as social and economic emancipation. Moreover, it is expected that the COVID-19 pandemic will leave significant traces in mental health for both health care professionals and society as a whole. It is also a central puzzle piece in the wider shift away from a system of sick care to one of health, which supports physical and mental well-being and early intervention to preventive healthcare. Today, science and technology offer new venues for innovation in mental health prevention, treatment, and care. It offers the possibility to profoundly revisit the way we think about mental illnesses and fundamentally change their trajectories. The Summit will include a high-level session to debate the prospects of advancing a European agenda for mental health.
SESSION HIGHLIGHTS
H.M. the Queen of the Belgians: “Mental health and well being covers a broad spectrum. To address mental health, we need to start with prevention and promotion of a healthy lifestyle. Then counselling & tailored interventions.” – H.M. the Queen of the Belgians @MonarchieBe
Hans Kluge: “No one has been spared by mental distress. #MentalHealth has become a core priority in Europe.
The commitement of H.M. the Queen of the Belgians on mental health is very much appreciated.”/ “We still have a long road ahead in tackling COVID-19 which includes restrictions, lockdowns and isolation and this has a severe impact on #MentalHealth” – @hans_kluge @WHO_Europe #UnitedActionForBetterHealth
Paul Stoffels: “¼ people in the world will be affected by mental health disorders in their life. Stygma continues to be a persistent challenge than impeaches people from seeking the necessary help they need.”/ “Johnson&Johnson is fully commited to innovation & mental health. The challenge is too large, a collaboration between partners & a multistakeholder approach is key. We have been working to improve awareness and reduce stygma” – Paul Stoffels @JNJNews @JNJGlobalHealth
13:15 – 13:30
A CONVERSATION WITH VINCENZO COSTIGLIOLA, PRESIDENT OF THE EUROPEAN MEDICAL ASSOCIATION
Vincenzo Costigliola
President
European Medical Association
Chris Burns
Independent Journalist
SESSION HIGHLIGHTS
Vincenzo Costigliola: “General practitioners need more equipment, technology and training & we need more coordination between the GP, the hospitals and the authorities.”/”How would you do tackle the pandemic differently? #EmergencyCulture “We need to prepare the doctors with precise information & equipment.” – Vincenzo Costigliola, President of the European Medical Association @MedicalEmanet
13:30 – 13:40
A CONVERSATION WITH FRANCESCO BUONARROTI, VP AND CIO BUSINESS TECHNOLOGY OF JOHNSON & JOHNSON
Francesco Buonarroti
VP and CIO Business Technology
Johnson & Johnson
Maria Tadeo
Reporter for Bloomberg Television
SESSION HIGHLIGHTS
Francesco Buonarroti: “Transparency can help to unlock the potential for data.. this is why we (at Johnson and Johnson) are trying to promote clinic research data sharing.”/”only 20 percent of the #data collected are currently re-used, there is a huge potential to improve.” – Francesco Buonarroti @JNJGlobalHealth @JNJNews
13:40 – 14:00
MEET THE EXPERT - BIOS AND IPROCURESECURITY PROJECTS
Csaba Ortutay
Project coordinator
BioS Project
Joachim Berney
Project coordinator
iProcureSecurity Project
Laura Elisa Dorn
Project coordinator
BioS Project
Felicia Balan
European Health Summit Project Manager
European Business Summits
BioS project
BioS project stands for “Digital Skills on Computational Biology for Health Professionals” and is co-funded by the European Commission. BioS aims at advancing digital skills of healthcare professionals through the delivery of innovative vocational curricula on Computational Biology & Bioinformatics. Our purpose is to provide participants with knowledge and skills allowing them to tackle concurrent challenges in EU healthcare systems and services in benefit of the health of EU citizens.
iProcureSecurity project
In response to the fragmentation of Emergency Medical Services in Europe and the pluralistic landscape of practitioners, the iProcureSecurity project aims to identify existing capability gaps, to monitor research and development initiatives and, finally, to define the needs and technical documentation for the innovation procurement phase. All stakeholders who are linked in some ways to emergency medical services are invited to have a deeper look at the project website: www.iprocuresecurity.eu .
SESSION HIGHLIGHTS
Joachim Berney: “How did @procuresecurity reach its objectives? “First, we mobilized all staff linked with emergency medical services such as GPs, experts, hospitals, public institutions & created an interactive platform gathering stakeholders.” (1/2) / “We also analysed the #European emergency medication services ecosystem, its capability gaps, challenges & needs. This was carried out through different activities such as analytical research, surveys, webinars & workshops.”(2/2) – Joachim Berney @procuresecurity
Laura Elisa Dorn: “The creation & conduction of the BioS online course allows to take on current challenges in the European healthcare system, services and policies with the ultimate goal to improve healthcare services for European citizens.”/ “The BioS project aims at achieving a greater awareness on Bioinformation through policy briefs, policy recommendations, publication of articles, dissemination events & social media channels” – Laura Elisa Dorn @BiosProject1
Csaba Ortutay: “The technology is cheap and capable, and it is there to be used. We just need to train the medical professionals to use the #technological advances in their everyday practice.”/ “My personal mission is to provide #education and courses to people at universities so that the bioinformatics gap does not hinder findings & diagnostics.” – Csaba Ortutay @BiosProject1
14:00 – 14:25
A CONVERSATION WITH THOMAS STEFFEN, GERMAN PERMANENT STATE SECRETARY
Thomas Steffen
Permanent State Secretary
The Federal Republic of Germany
Maria Tadeo
Reporter for Bloomberg Television
SESSION HIGHLIGHTS
Thomas Steffen: “The stance of the German government is clear: the #COVID19 #Vaccine will not be mandatory. We will do our best to convince the population and win its trust. Vaccination will be done on a voluntary basis.”/ “It is key that we sit together on a federal level and communicate about this #vaccine in a clear and concise way. We need to get the right messages out about the COVID vaccine.” -Thomas Steffan – Permanent State Secretary of Germany. #HealthSummitEU
14:30 – 14:45
MEET THE EXPERT WITH AB INBEV
David De Schutter
Head of Global Innovation & Technology Center
GITEC
AB InBev
Chris Burns
Independent Journalist
SESSION HIGHLIGHTS
David De Schutter: “@ABInBev_EU has a well-established supply chain which could help supply vaccines in areas such as Subsaharan Africa which are otherwise difficult to reach. They can also help to scale manufacturing for other medical supplies both in Europe and around the world.”/ “
David de Schutter – Head of Global Innovation @ABInBev_EU discusses the timeline of how they created and supported efforts to produce biocides, mouth masks and even vaccines from the very start of the global #COVID19 pandemic. #healthsummiteu
When discussing preparing for future pandemics, David de Schutter mentions the effectiveness of ‘an agile task force’ which helped @ABInBev_EU to roll out measures very quickly. In addition, it is important to have timely government support for instance for licencing.
14:45 – 15:00
A CONVERSATION WITH MICHEL GOLDMAN, FOUNDER AND CO-DIRECTOR OF THE I³H INSTITUTE
Michel Goldman
Founder and Co-Director
I3h Institute
Chris Burns
Independent Journalist
SESSION HIGHLIGHTS
Michel Goldman: “Among all pharmaceuticals, vaccines are the ones with the greatest number of safety rules and regulatory agencies. Side effects will only be visible when a hundred thousand people will get vaccinated.”/ “2 elements in the fight against vaccine skepticism: 1- transparency from all stakeholders(vaccine manufacturers, public health authorities, scientists) 2- education as of primary school to make our citizens much more “vaccine savvy”.” @MichelGoldman @I3h_Institute
15:00 – 16:00
INTERACTIVE PANEL: EMBEDDING TRUST IN THE HEALTH DATA ECOSYSTEM
Didier Reynders
Commissioner for Justice
European Commission
Casper Klynge
Vice President for European Government Affairs
Microsoft
Eila Mäkipää
State Secretary to the Minister of
Family Affairs and Social Services Krista Kiuru
The Republic of Finland
Francesco Buonarroti
VP and CIO Business Technology
Johnson & Johnson
Maria Tadeo
Reporter for Bloomberg Television
The health data ecosystem is rapidly being overturned by new sources of data, capabilities, and stakeholders. It allows for new capabilities for the generation, storage, and exploitation of data across many aspects of human health, and introduces entirely new configurations and skills. The opportunities for clinical research, health care practice and to boost citizens’ quality of life are paramount. It is also a prerequisite for the digital health transformation. However, public concerns about the involvement of private companies persist, as well as the security, reliability, and privacy of data. Overcoming the “trust deficit” will be an existential requirement to integrate the new environment in health systems. The Summit will debate innovative policy approaches that need to be developed in order to tackle this trust deficit and unlock the digital transformation of Europe’s healthcare.
SESSION HIGHLIGHTS
Didier Reynders: #COVID19 #Vaccine “Trust is the key-word. We must build trust between the consumers and the producers, between the citizens and the authorities.”/ “All major platforms such as Facebook want to collaborate against misinformation by removing fake news & organising an open debate.”
Casper Klynge: “When it comes to #data especially #healthdata from the industry perspective – size matters. Industry leaders need access to #bigdata sets, and more public-private partnerships will help to ensure the responsible and #ethicsal use of this data.”
/ “Agreeing with @dreynders, a fundamental aspect when sharing data: it must be based on trust and safety. It is crucial to ensure the security around patience privacy.” – @KlyngeC @MicrosoftEU
3 areas that are important to help move forward with digital data space according to Casper Klynge @MicrosoftEU:
1. More international collaboration
2. Trust and safety
3. Need to fight the digital divide
Francesco Buonarroti: “European #health #data space is more important than ever before. This, coupled with the fair principles of data, gives a clear framework for users to be protected.”/” European #health #data space is more important than ever before. This, coupled with the fair principles of data, gives a clear framework for users to be protected. – @JNJGlobalHealth @JNJNews
Eila Mäkipää – State Secretary of Finland has discussed the critical importance of addressing human rights, ethics and data privacy concerns when it comes to #healthdata and #covid19 tracking apps.
16:00 – 17:00
INTERACTIVE PANEL: TACKLING COVID-19 PUBLIC-PRIVATE PARTNERSHIPS FOR THE WORLD
Peter Piot
Special Advisor to the President of the European Commission London School of Hygiene and Tropical Medicine
Philippe Aghion
Professor of Economics
College de France
Michel Goldman
Founder and Co-Director
I3h Institute
Luc Debruyne
Strategy advisor
Coalition for Epidemic Preparedness Innovations
CEPI
Andrew Jack
Global Education Editor
Financial Times
SESSION HIGHLIGHTS
Michel Goldman: “It is critical to test people very early, get results early and then to take the right measures in terms of quarantine. Europe is behind when it comes to testing. We need to be more reactive in developing diagnostics and #vaccines.”/ “Strenght of European science in the field of vaccine: @pfizer #vaccine was born in Germany! We must ensure that the discoveries made in our universities are further developed in our countries.” – @MichelGoldman @I3h_Institute
Peter Piot: “Harmony in the EU is key. Since every country has a #healthcare system, with quarantine rules that differ from country to country. This is an opportunity to develop a European health union and to ensure we are better prepared for the next one.”/ “Crisis expose the fault lines in society. Social protection and safety nets differ complety from one region of the world to another. The positive aspect of this crisis is the solidarity that it has generated across Europe.” – Peter Piot @LSHTM
Philippe Aghion: “US states that unlocked too early have worse economic outcomes. It’s important to overcome the virus to grow in the long term. The “Stop & go” strategy against #COVID19 doesn’t allow to make long term plans and to ensure a strong economic growth.”/
Next steps globally “Public-private partnerships are crucial. Great initiative: launch of HERA @vonderleyen. Challenge: making these partnerships fit for purpose, move away from bureaucracy & ensure fair access to innovative medicines & technologies.”/”Good lesson of the pandemic in Europe: Boost for innovation & proactiveness!”
Luc Debruyne: “Unprecedented #scientific #progress has been made over the course of the last year. That is not to discount the decade of research done before. We can only get out of this crisis with a global effort and #collaboration”
17:00 – 18:00
CLOSING PANEL: COVID-19 VACCINES: HOPES AND CHALLENGES
Jean Stéphenne
Chairman of the Supervisory Board
CureVac
Melanie Saville
Director of Vaccine Development
Coalition for Epidemic Preparedness Innovations
CEPI
Sandra Gallina
Director-General DG SANTE
European Commission
Iskra Reic
Executive Vice-President for Europe and Canada
AstraZeneca
Heidi Larson
Director
Vaccine Confidence Project
Andrew Jack
Global Education Editor
Financial Times
The development of vaccines is a lengthy and complex process. Efforts to support the acceleration of this process while ensuring the development of safe vaccines should be reinforced. This needs to be complemented with securing access to vaccines that can help protect European citizens and safeguard its international distribution. In order to guarantee optimal access, strong partnerships are needed between private manufacturers, regulatory authorities, and national and international public health services. The European Union can be at the forefront of these partnerships. The Summit will discuss lessons learned from the development of Covid-19 vaccines to this date and will debate the way in which existing governance of vaccines can be improved in order to prepare us better for future pandemics.
SESSION HIGHLIGHTS
SESSION HIGHLIGHTS
Iskra Reic: “If there is one lesson that we should take forward, it is that none of us can handle the #health crisis in isolation. We need collaboration and working together across sectors. Though this is not always easy it is essential.”/ “The partnership across different sectors (academia, government, manufacturers, experts) helped us learn and figure out how to develop a #COVID19 #vaccine in these unprecedented times.” – Iskra Reic @AstraZeneca
Heidi Larson: “The next few months are critical. We need to make sure to communicate with the public the ‘why’, to fill in the story to avoid disinformation and misinterpretation.”/ “Emotional epidemiology” the willingness of people to get vaccined is closely linked to the severity of the pandemic at a certain point in time.” / “We need to use the momentum created around the #COVID19 #vaccine to build trust globally regarding vaccination” – @ProfHeidiLarson @vaccine_trust
Jean Stéphenne: “When it comes to a #covidvaccine, it is critical for the industry to prove #credibility. We need to need to re-explain the basis of #vaccination as younger people have not seen the disease.”/ “The elderly will be the first ones to get vaccinated. The industry will take around a year to develop the necessary amount of scientific data before offering a vaccine to young people.” – Jean Stéphenne @CureVacRNA
Melanie Saville: “We need to scale vaccine production to ensure the delivery of the #vaccines and accessibility. There are lots of bottlenecks in the capacity of manufacturing.” / “This is not the end for #vaccines… there needs to be additional research and continual monitoring of vaccines with quality and safety effectiveness studies Many countries do not have the facility for that continual monitoring” / “The world will rely on Europe’s outcomes and it is critical that this data is shared. To help #vulnerable populations around the world get #vaccines.” – Melanie Saville @CEPIvaccinesCEPI
Sandra Gallina: “One of the most important elements in the #pandemic is that Europe has spoken with one voice. Going forward with the #vaccine strategy it needs to be affordable and accessible to all member states.” – @SandraGallina of @EU_Commission DG Sante.
Heidi Larson: “The next few months are critical. We need to make sure to communicate with the public the ‘why’, to fill in the story to avoid disinformation and misinterpretation.”/ “Emotional epidemiology” the willingness of people to get vaccined is closely linked to the severity of the pandemic at a certain point in time.” / “We need to use the momentum created around the #COVID19 #vaccine to build trust globally regarding vaccination” – @ProfHeidiLarson @vaccine_trust
Jean Stéphenne: “When it comes to a #covidvaccine, it is critical for the industry to prove #credibility. We need to need to re-explain the basis of #vaccination as younger people have not seen the disease.”/ “The elderly will be the first ones to get vaccinated. The industry will take around a year to develop the necessary amount of scientific data before offering a vaccine to young people.” – Jean Stéphenne @CureVacRNA
Melanie Saville: “We need to scale vaccine production to ensure the delivery of the #vaccines and accessibility. There are lots of bottlenecks in the capacity of manufacturing.” / “This is not the end for #vaccines… there needs to be additional research and continual monitoring of vaccines with quality and safety effectiveness studies Many countries do not have the facility for that continual monitoring” / “The world will rely on Europe’s outcomes and it is critical that this data is shared. To help #vulnerable populations around the world get #vaccines.” – Melanie Saville @CEPIvaccinesCEPI
Sandra Gallina: “One of the most important elements in the #pandemic is that Europe has spoken with one voice. Going forward with the #vaccine strategy it needs to be affordable and accessible to all member states.” – @SandraGallina of @EU_Commission DG Sante.
18:00 – 18:05
CLOSING PANEL: COVID-19 VACCINES: HOPES AND CHALLENGES
Arnaud Thysen
Director General
European Business Summits
Speakers
H. M. the Queen of the Belgians
Ursula von der Leyen
President of the European Commission
Didier Reynders
European Commissioner for Justice
Olivier Véran
Minister of Solidarity and Health
of The French Republic
Bernd Montag
CEO of Siemens Healthineers
Peter Piot
Special Advisor to the President
of the European Commission
Thomas Steffen
Permanent State Secretary
of The Federal Republic of Germany
Jean Stéphenne
Chairman of the Supervisory Board
of CureVac
Philippe Aghion
Professor of Economics
of College de France
Frank Vandenbroucke
Deputy Prime Minister and
Minister for Social Affairs and Public Health
of The Kingdom of Belgium
Kalle Killar
Deputy Secretary General
on E-services Development and Innovation
of The Republic of Estonia
Casper Klynge
Vice President for European Government Affairs of Microsoft
Paul Stoffels, M.D.
Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson
Michel Goldman
Founder and Co-Director of I3h Institute
Khalil Rouhana
Deputy DG for Communications Networks, Content and Technology of the European Commission
Hans Kluge
Regional Director for Europe of the WHO
Melanie Saville
Director of Vaccine Development of Coalition for Epidemic Preparedness Innovations (CEPI)
Reda Guiha
Regional President
International Development Markets Rare Disease of Pfizer
István Ujhelyi
Member of the European Parliament
Thomas Kostera
Senior Expert of Bertelsmann Stiftung
Johannes Schildt
CEO and Co-founder of KRY
Jean-Charles Samuelian-Werve
CEO and Co-founder of Alan
Sandra Gallina
Director-General DG SANTE
of the European Commission
Eila Mäkipää
State Secretary to the Minister of
Family Affairs and Social Services Krista Kiuru
of The Republic of Finland
Iskra Reic
Executive Vice-President for Europe
and Canada of AstraZeneca
Heidi Larson
Director of Vaccine Confidence Project
Anya Gregory
Communications and Research Manager
of the European Business Summits
Luc Debruyne
Strategy advisor of Coalition for Epidemic Preparedness Innovations (CEPI)
Arnaud Thysen
Director General of the European Business Summits
Chris Burns
Independent Journalist
David De Schutter
Head of Global Innovation & Technology Center
GITEC of AB InBev
Sébastien Deletaille
CEO and Co-founder of Rosa
Andrew Jack
Global Education Editor of The Financial Times
Vincenzo Costigliola
President of the European Medical Association
Csaba Ortutay
Project coordinator of the BioS Project
Laura Elisa Dorn
Project coordinator of the BioS Project
Joachim Berney
Project coordinator
of the iProcureSecurity Project
Francesco Buonarroti
VP and CIO Business Technology
of Johnson & Johnson
Giulia Del Brenna
DG GROW Health files coordinator
of the European Commission
Sam Proesmans
Public Health Advisor focusing on
COVID-19 of Cabinet of the Prime Minister of Belgium
